This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy.

logo.svg
About us
Company Overview
Founders and Leadership Team
History
Research and Development
Pipeline
Discovery Research
Clinical Development
Pharmaceutical R&D
Quality System
Expanded Access Policy
Investor Relationship
Partnering
News Release
Company News
Media Report
Industrial News
Careers
Contact us
中
f1_banpc.png
f1_banph.jpg

News Release

> News Release
> Company News
Company News
Media Report
Industrial News
guanwangtupian.jpg

和其瑞医药HMI-115获得美国FDA快速通道认定，加速全球研发进程

MORE
guanwangtupian.jpg

和其瑞医药入选Clarivate发布“开拓女性健康新领域的七家企业”

MORE
guanwangtupian.jpg

潜在全球首创子宫内膜异位症治疗药物HMI-115 II期临床试验结果发表于《柳叶刀-妇产科学与女性健康》

MORE
guanwangtupian-157.jpg

和其瑞医药宣布潜在全球首创子宫内膜异位症治疗药物成功完成全球II期临床试验

MORE
guanwangtupian-899.jpg

和其瑞医药入围2025年盖伦奖“最佳初创企业（Best Startup）”提名名单

MORE
guanwangtupian-94.jpg

和其瑞医药出席BIOCHINA2025, 协力探索生物医药无界创新

MORE

Follow Us

g_img1.png

Top